Latest Telix Pharmaceuticals (ASX:TLX) News
Page 3
Page 3 of 5
Telix and Regeneron Launch $40M Radiopharma Partnership Targeting Hard-to-Treat Cancers
13 Apr 2026
Market Wrap - Week 15 (6 Apr -> 10 Apr) 2026
11 Apr 2026
Healthcare Wrap - Week 15 (6 Apr -> 10 Apr) 2026
11 Apr 2026
FDA Accepts Telix’s NDA for Glioma Imaging Agent TLX101-Px with September Review Target
10 Apr 2026
Telix Reports 11% Q1 Revenue Growth and Advances Prostate Cancer Therapy Trials
7 Apr 2026
Market Wrap - Week 12 (16 Mar -> 20 Mar) 2026
21 Mar 2026
Healthcare Wrap - Week 12 (16 Mar -> 20 Mar) 2026
21 Mar 2026
Telix Resubmits FDA Application for Brain Cancer Imaging Agent Pixclara®
16 Mar 2026
Healthcare Wrap - Week 11 (9 Mar -> 13 Mar) 2026
14 Mar 2026
Telix’s ProstACT Phase 3 Part 1 Confirms Safety, Paving Way for Global Expansion
10 Mar 2026
Market Wrap - Week 8 (16 Feb -> 20 Feb) 2026
21 Feb 2026
Healthcare Wrap - Week 8 (16 Feb -> 20 Feb) 2026
21 Feb 2026